Dear Mahesh,
How wonderful hearing from you. Thank you for letting me know of your plans personally and I wish you luck in your new venture. I am now a Consultant at Berlin Pharmaceuticals and help Eaglemont on a case by case basis as well.
However before you leave, we really would like the issue below cleared up as soon as possible and request that you let me know whom I can talk to (phone contact) and/or if this project is worth pursuing. Your honest and candid decision on this would be helpful as it is hard to do business when no one shows interest in responding or in the project that we have worked so hard to promote for Unimark.
I do not want Eaglemont to pursue Immipinem if this is going to create problems in the future. LBS have already registered the product and are now having issues sourcing from Unimark. I believe they registered with Jeil product and I believe that it is now being manufactured in Unimark's own plant.
I would appreciate it if someone could give me a clear picture of what is going on so we can explain to our client candidly and let them make the decision if they still wish to pursue with yourselves.
I value our friendship and business association and hope you can do me this favour before you leave.
Many thanks and best regards
Marisa Narula